行情

AWH

AWH

Aspira Women`s Health
NASDAQ

实时行情|Nasdaq Last Sale

1.110
+0.010
+0.91%
交易中 10:10 01/27 EST
开盘
1.110
昨收
1.100
最高
1.120
最低
1.080
成交量
2.56万
成交额
--
52周最高
10.54
52周最低
0.9900
市值
1.24亿
市盈率(TTM)
-4.2270
分时
5日
1月
3月
1年
5年
ViacomCBS secures rights to stream Premier League soccer matches in Latin America
reuters.com · 01/13 12:00
Aspira Women’s Health reports Q4 updates; partners Axia on genetics platform
Aspira Women’s Health (AWH +1.2%) provided preliminary Q4 operational results and announced an agreement with Axia Women’s Health to launch Aspira Synergy Genetics platform. The company said OVA1 volume in Q4 grew
Seekingalpha · 01/05 17:17
Aspira Women’s Health Appoints Minh Merchant as General Counsel
AUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that Minh Merchant will join the Company as General Counsel and Corporate Secretary, effective Jan. 4, ...
GlobeNewswire · 01/05 13:00
Aspira Women's Health 公布第四季度运营指标并提供其 OvaWatch 和 EndoCheck 计划的更新
Fourth quarter OVA1 volume grew 23.4% to 4,750 units Plans underway for staged launches of EndoCheck and OvaWatch AUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today...
GlobeNewswire · 01/05 13:00
Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform
Axia Women’s Health is one of the largest women’s health networks in the United States serving nearly half a million women a yearAUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health...
GlobeNewswire · 01/05 13:00
Soccer-Players stunned as Coventry United to enter voluntary liquidation
reuters.com · 2021/12/23 22:42
约旦女王“从来没有”成为公关人员特雷维安·库蒂的客户——王室女发言人
reuters.com · 2021/12/16 23:07
Tennis-Shenzhen Open missing as WTA announces schedule for first half 2022
reuters.com · 2021/12/07 08:16
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解AWH最新的财务预测,通过AWH每股收益,每股净资产,每股现金流等数据分析Aspira Women`s Health近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

50.00%强力推荐
50.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测AWH价格均价为4.000,最高价位4.000,最低价为4.000。
最高4.000
均价4.000
最低4.000
现价1.110
EPS
实际EPS
预期EPS
-0.46-0.35-0.23-0.12
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 108
机构持股: 3,551.54万
持股比例: 31.67%
总股本: 1.12亿
类型机构数股数
增持
32
251.60万
建仓
14
48.41万
减持
24
157.95万
平仓
17
261.12万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.69%
制药与医学研究
+1.72%
高管信息
Non-Executive Chairman/Independent Director
James Lafrance
President/Chief Executive Officer/Director
Valerie Palmieri
Chief Financial Officer
Robert Beechey
General Counsel/Secretary
Mint Merchant
Independent Director
Veronica Jordan
Independent Director
Nicole Sandford
公告日期
每股分红
除权日期
2017/05/22
每股分红:USD 0
2017/07/07
2017/05/22
每股特殊分红:USD 5
2017/07/07
AWH 简况
Aspira Women's Health Inc致力于发现、开发和商业化帮助医生诊断、治疗和改善女性的妇科健康结果的诊断和生物分析解决方案。其产品包括OVA1、Overa和OVA1plus。OVA1是一项血液检测,除了医生对盆腔肿块女性的临床评估外,还可以在计划手术前确定哪些女性有患恶性卵巢肿瘤的高风险。OVERA是第二代生物标志物,旨在保持OVA1的高灵敏度,同时提高特异性。OVA1plus是一种反射性产品,主要使用OVA1和OVERA作为OVA1中间范围结果的确认。它还正在开发另外三种产品和相关服务,包括两种诊断算法OVASight和EndoCheck,以及一种高风险诊断算法OVAInherit,适用于有或没有盆腔肿块且具有卵巢癌遗传倾向的患者。

微牛提供Aspira Women's Health Inc(NASDAQ-AWH)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的AWH股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AWH股票基本功能。